Artisan Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-316,293
| Closed | -$4.46M | – | 311 |
|
2022
Q2 | $4.46M | Sell |
316,293
-910,678
| -74% | -$12.8M | 0.01% | 300 |
|
2022
Q1 | $29.7M | Sell |
1,226,971
-167,868
| -12% | -$4.07M | 0.04% | 263 |
|
2021
Q4 | $32.6M | Sell |
1,394,839
-38,119
| -3% | -$890K | 0.04% | 271 |
|
2021
Q3 | $23.8M | Sell |
1,432,958
-11,224
| -0.8% | -$186K | 0.03% | 284 |
|
2021
Q2 | $35.2M | Sell |
1,444,182
-113,618
| -7% | -$2.77M | 0.04% | 266 |
|
2021
Q1 | $40.2M | Buy |
1,557,800
+199,130
| +15% | +$5.14M | 0.05% | 252 |
|
2020
Q4 | $72.6M | Buy |
1,358,670
+361,728
| +36% | +$19.3M | 0.09% | 196 |
|
2020
Q3 | $41.1M | Sell |
996,942
-331,767
| -25% | -$13.7M | 0.06% | 221 |
|
2020
Q2 | $64.4M | Buy |
1,328,709
+64,541
| +5% | +$3.13M | 0.1% | 174 |
|
2020
Q1 | $53.4M | Sell |
1,264,168
-39,372
| -3% | -$1.66M | 0.11% | 169 |
|
2019
Q4 | $55.8M | Sell |
1,303,540
-243,665
| -16% | -$10.4M | 0.1% | 173 |
|
2019
Q3 | $55.7M | Sell |
1,547,205
-7,453
| -0.5% | -$268K | 0.11% | 169 |
|
2019
Q2 | $41.6M | Buy |
1,554,658
+422,829
| +37% | +$11.3M | 0.08% | 189 |
|
2019
Q1 | $30.4M | Buy |
1,131,829
+879,311
| +348% | +$23.6M | 0.06% | 207 |
|
2018
Q4 | $4.08M | Buy |
+252,518
| New | +$4.08M | 0.01% | 251 |
|